Related Experiment Video
Updated: May 30, 2026

Sagittal Plane Kinematic Gait Analysis in C57BL/6 Mice Subjected to MOG35-55 Induced Experimental Autoimmune Encephalomyelitis
Published on: November 4, 2017
Gait abnormalities in multiple sclerosis: pathogenesis, evaluation, and advances in treatment
Michelle H Cameron1, Joanne M Wagner
1Portland VA Medical Center, OR, USA. cameromi@ohsu.edu
Multiple sclerosis (MS) causes significant gait dysfunction, impacting speed and stability. Treatments like exercise, medication, and assistive devices can improve walking ability in MS patients.
Area of Science:
- Neurology
- Rehabilitation Medicine
Background:
- Multiple sclerosis (MS) is a central nervous system demyelinating disease.
- Gait dysfunction is a common and debilitating symptom in MS patients.
Purpose of the Study:
- To review the characteristics of gait dysfunction in MS.
- To discuss methods for identifying and treating gait problems in MS.
Main Methods:
- Review of clinical measures, timed tests, and patient-reported outcomes.
- Analysis of observational, instrumented walkway, and 3D gait analysis techniques.
- Examination of various therapeutic interventions for MS gait dysfunction.
Main Results:
- MS gait is characterized by reduced speed, endurance, step length, cadence, and joint motion.
- Increased metabolic cost and variability of gait are also observed in MS.
- Multiple treatment strategies exist, targeting specific underlying causes of dysfunction.
Conclusions:
- Gait dysfunction in MS is multifaceted, affecting multiple parameters of walking.
- Accurate assessment is crucial for directing targeted and effective treatments.
- Interventions including exercise, medication, orthoses, and assistive devices can improve gait in MS.
Related Concept Videos
Multiple Sclerosis l: Introduction
Parkinson's Disease: Overview
Parkinson Disease ll: Pathophysiology
Spinal Cord Injury ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology
Alterations in Muscle Tone lll

